Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  SUGAMMADEX

SUGAMMADEX

Basic information Safety Supplier Related

SUGAMMADEX Basic information

Product Name:
SUGAMMADEX
Synonyms:
  • Shu Glucose
  • SUGAMMADEX
  • Org 25969
  • Sugammadex [inn]
  • Unii-361lpm2T56
  • SugaMMadex SodiuM
  • Sugammagex
  • Bridion
CAS:
343306-71-8
MF:
C72H112O48S8
MW:
2002.15
EINECS:
253-874-2
Mol File:
343306-71-8.mol
More
Less

SUGAMMADEX Chemical Properties

Melting point:
>208°C (dec.)
Density 
1.559±0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Room Temperature
solubility 
Aqueous Acid (Slightly), Water (Slightly, Sonicated)
pka
3.42±0.10(Predicted)
form 
Solid
color 
White to Pale Beige
Stability:
Hygroscopic
More
Less

SUGAMMADEX Usage And Synthesis

Description

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. Sugammadex provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.

Uses

6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-Cyclodextrin, also known as Sugammadex, is used to reverse postoperative residual neuromuscular blockade.

Uses

Reversal agent for neuromuscular blocking drugs.

Definition

ChEBI: An octasaccharide derivative that is gamma-cyclodextrin in which all eight primary hydroxy groups are replaced by 2-(carboxyethyl)sulfanyl groups. Used (as the octasodium salt) for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery.

Synthesis

Bromination of |?-cyclodexdrin 127 with the Vilsmeier-Haack reagent prepared by reaction of bromine with triphenylphospine in DMF gave the per-6-bromo-|?-cyclodextrin 128 in 95-98% yield. Nucleophilic displacement of the bromines of 128 with methyl 3-mercaptopropionate (129) and cesium carbon-ate at 50??C in DMF gave 6-perdeoxy-6-per(2-methoxycarbonylethyl) thio-|?-cyclodextrin 130 as a white powder. Saponification of the esters of 130 was accomplished by reaction with aqueous sodium hydroxide solution to provide sugammadex (XVII) as a glassy solid in 52% yield for the 2 steps.

SUGAMMADEXSupplier

Nanjing Feihao Technology Co., Ltd. Gold
Tel
025-58855213 15366065068
Email
hongjiling@feihongtec.com
Shandong Mingfeng Pharmaceutical and Technology Co. Ltd Gold
Tel
-1345456643 15315114555
Email
1345456643@qq.com
CHANGZHOU PHARMACEUTICAL FACTORY Gold
Tel
519-88821493 18915891730
Email
shm@czpharma.com
Jinan Chenghui Shuangda biological Co., LTD
Tel
0531-58897003 15550412551
Email
market@jnchsd.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com